Table 2 Clinical characteristics and associations for T&CM use
Total N = 1307 | % | T&CM, N = 408 | % | No T&CM, N = 899 | % | p-value | |
|---|---|---|---|---|---|---|---|
Self-reported health | 0.283 | ||||||
Medium to good | 1207 | 92.3 | 372 | 91.2 | 835 | 92.9 | |
Poor | 100 | 7.7 | 36 | 8.8 | 64 | 7.1 | |
Cancer site first diagnosis | 0.309 | ||||||
Breast | 262 | 20.0 | 98 | 24.0 | 164 | 18.2 | |
Female genital organs | 105 | 8.0 | 32 | 7.8 | 73 | 8.1 | |
Prostate | 286 | 21.9 | 74 | 18.1 | 212 | 23.6 | |
Other male genital organs | 49 | 3.7 | 14 | 3.4 | 35 | 3.9 | |
Respiratory organs | 31 | 2.4 | 9 | 2.2 | 22 | 2.4 | |
Melanoma and skin | 127 | 9.7 | 42 | 10.3 | 85 | 9.5 | |
Colon | 99 | 7.6 | 29 | 7.1 | 70 | 7.8 | |
Other digestive organs | 72 | 5.5 | 23 | 5.6 | 49 | 5.5 | |
Hematologic* | 93 | 7.1 | 25 | 6.1 | 68 | 7.6 | |
Other cancers | 183 | 14.0 | 62 | 15.1 | 121 | 13.5 | |
Metastasis at first diagnosis ! | 0.779 | ||||||
Metastasis | 334 | 30.6 | 109 | 31.5 | 225 | 30.2 | |
No metastasis | 754 | 69.2 | 236 | 68.2 | 518 | 69.6 | |
Unknown | 2 | 0.2 | 1 | 0.3 | 1 | 0.1 | |
Time since first cancer diagnosis | 0.072 | ||||||
less than a year | 117 | 9.0 | 38 | 9.3 | 79 | 8.8 | |
1–5 years | 485 | 37.1 | 167 | 40.9 | 318 | 35.4 | |
6–10 years | 265 | 20.3 | 86 | 21.1 | 179 | 19.9 | |
more than 10 years | 440 | 33.7 | 117 | 28.7 | 323 | 35.9 | |
Mean time since first cancer diagnosis (SD) | 9.20 (9.299) | 8.57 (9.489) | 9.49 (9.202) | 0.098 | |||
Age at first cancer diagnosis | 0.132 | ||||||
0–20 years | 31 | 2.7 | 7 | 1.9 | 24 | 3.1 | |
21–49 years | 344 | 30.0 | 122 | 33.6 | 222 | 28.4 | |
50 years and above | 770 | 67.2 | 234 | 64.5 | 536 | 68.5 | |
Number of cancer diagnoses | .046 | ||||||
Cancer once | 1067 | 81.6 | 346 | 84.8 | 721 | 80.2 | |
Cancer twice or more times | 240 | 18.4 | 62 | 15.2 | 178 | 19.8 | |
Only one treatment modality ! | 0.340 | ||||||
Surgery | 184 | 41.2 | 54 | 36.0 | 130 | 43.8 | |
Chemotherapy | 57 | 12.8 | 19 | 12.7 | 38 | 12.8 | |
Radiotherapy | 186 | 41.6 | 71 | 47.3 | 115 | 38.7 | |
Hormone therapy | 20 | 4.5 | 6 | 4.0 | 14 | 4.7 | |
Multimodal treatment ! | |||||||
Surgery and CT | 372 | 28.5 | 107 | 26.2 | 265 | 29.5 | 0.227 |
Surgery and RT | 523 | 40.0 | 165 | 40.4 | 358 | 39.8 | 0.832 |
Surgery and HT | 274 | 21.0 | 70 | 17.2 | 204 | 22.7 | 0.023 |
CT and RT | 231 | 17.7 | 67 | 16.4 | 164 | 18.2 | 0.424 |
CT and HT | 193 | 14.8 | 58 | 14.2 | 135 | 15.0 | 0.705 |
Surgery, CT and HT | 322 | 24.6 | 93 | 22.8 | 229 | 25.5 | 0.298 |
CT, HT and RT | 236 | 18.1 | 69 | 16.9 | 167 | 18.6 | 0.469 |
Surgery, HT and RT | 293 | 22.4 | 75 | 18.4 | 218 | 24.2 | 0.018 |
Surgery, CT and RT | 336 | 25.7 | 95 | 23.3 | 241 | 26.8 | 0.177 |
Surgery, CT, RT and HT | 337 | 25.8 | 96 | 23.5 | 241 | 26.8 | 0.209 |